Publication | Open Access
Open-label Clinical Trial of Niraparib Combined With Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast Cancer
413
Citations
32
References
2019
Year
ClinicalTrials.gov identifier: NCT02657889.
| Year | Citations | |
|---|---|---|
Page 1
Page 1